Yong-Zhi Wang (Yongzhi Wang)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Inflammatory Response

Top Venues

NPJ precision oncology

Journal of hematology & oncology

CNS neuroscience & therapeutics

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Rui-Chao Chai, Songyuan An, Han Lin, Bo Pang, Hao Yan, Yun Liu, Yilin Wu, Long Wang, Xing Liu, Huiyuan Chen, Xueyu Yang, Qing Chang, Wenqing Jia, Yong-Zhi Wang
Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors. NPJ precision oncology 8 (1) (2024)
Rui-Chao Chai, Songyuan An, Han Lin, Bo Pang, Hao Yan, Yun Liu, Yilin Wu, Long Wang, Xing Liu, Huiyuan Chen, Xueyu Yang, Qing Chang, Wenqing Jia, Yong-Zhi Wang
Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors. NPJ precision oncology 8 (1) (2024)
Rui-Chao Chai, Songyuan An, Han Lin, Bo Pang, Hao Yan, Yun Liu, Yilin Wu, Long Wang, Xing Liu, Huiyuan Chen, Xueyu Yang, Qing Chang, Wenqing Jia, Yong-Zhi Wang
Sequencing of cerebrospinal fluid cell-free DNA facilitated early differential diagnosis of intramedullary spinal cord tumors. NPJ precision oncology 8 (1) (2024)
Rui-Chao Chai, Hao Yan, Song-Yuan An, Bo Pang, Hui-Yuan Chen, Quan-Hua Mu, Ke-Nan Zhang, Yao-Wu Zhang, Yu-Qing Liu, Xing Liu, Zheng Zhao, Tao Jiang, Yong-Zhi Wang, Wen-Qing Jia
Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma. Brain pathology (Zurich, Switzerland) (2023)
Yatian Li, Zhenyue Gao, Yuhong Wang, Bo Pang, Binbin Zhang, Ruxin Hu, Yuqing Wang, Chao Liu, Xuebin Zhang, Jingxuan Yang, Mei Mei, Yong-Zhi Wang, Xuan Zhou, Min Li, Yu Ren
Lysine methylation promotes NFAT5 activation and determines temozolomide efficacy in glioblastoma. Nature communications 14 (1) (2023)
Ruichao Chai, Guanzhang Li, Yuqing Liu, Kenan Zhang, Zheng Zhao, Fan Wu, Yuzhou Chang, Bo Pang, Jingjun Li, Yangfang Li, Tao Jiang, Yong-Zhi Wang
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma. Cancer biology & medicine 18 (1) (2021)
Rui-Chao Chai, Yu-Zhou Chang, Xin Chang, Bo Pang, Song Yuan An, Ke-Nan Zhang, Yuan-Hao Chang, Tao Jiang, Yong-Zhi Wang
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma. Journal of hematology & oncology 14 (1) (2021)
Yao-Wu Zhang, Rui-Chao Chai, Ren Cao, Wen-Ju Jiang, Wei-Hao Liu, Yu-Lun Xu, Jun Yang, Yong-Zhi Wang, Wen-Qing Jia
Clinicopathological characteristics and survival of spinal cord astrocytomas. Cancer medicine 9 (19) (2020)
Rui-Chao Chai, Ning Wang, Yu-Zhou Chang, Ke-Nan Zhang, Jing-Jun Li, Jun-Jie Niu, Fan Wu, Yu-Qing Liu, Yong-Zhi Wang
Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma. Cancer cell international 19 (2019)
Rui-Chao Chai, Ke-Nan Zhang, Yu-Qing Liu, Fan Wu, Zheng Zhao, Kuan-Yu Wang, Tao Jiang, Yong-Zhi Wang
Combinations of four or more CpGs methylation present equivalent predictive value for MGMT expression and temozolomide therapeutic prognosis in gliomas. CNS neuroscience & therapeutics 25 (3) (2018)